Highlights
A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.
Displaying items 1-12 of 61
» View wsbtradio.com items only
1
2
3
4
5
6
•
Next >
-
PRESS DIGEST - Sunday British business - May 19
ReutersLONDON, May 19 (Reuters) - British newspapers reported the following business stories on Sunday: The Sunday Telegraph CARR IN POLE POSITION TO BECOME CHAIRMAN OF BAE SYSTEMS Roger Carr, Chairman of Centrica and outgoing president of the...Tags: BAE Systems Plc., Marks & Spencer Ltd., Private Equity, United Kingdom, Finance
-
STOCKS NEWS US-Total option open interest stands at 2.74 mln contracts
ReutersReal-time equity news [E U] U.S. stock market report 0940 ET 16May2013 Total option open interest stands at 2.74 mln contracts -------------------------------------------------------------------------------- A total of 19.8 million contracts changed...Tags: Cisco Systems Inc., Barrick Gold Corporation, Bank of America Corp.
-
Bristol-Myers shares jump ahead of melanoma trial data
ReutersBy Doris Frankel and David Gaffen CHICAGO/NEW YORK, May 15 (Reuters) - Shares of drugmaker Bristol-Myers Squibb Co rose to a ten-year high on Wednesday ahead of results of an early stage trial for its new melanoma treatment, with heavy betting in the...Tags: Skin Cancer, Annual and Special Corporate Meetings, Oncology
-
Bristol melanoma drug combo marks new advance in immunotherapy
Reuters(For more stories on new cancer data, see ) By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance...Tags: Medical Research, Trials, Breast Cancer, GlaxoSmithKline PLC, Medical Specialization
-
Roche immunotherapy shows response over range of cancers
ReutersBy Bill Berkrot May 15 (Reuters) - An experimental Roche Holding AG drug that helps the immune system attack tumors was well tolerated and demonstrated an impressive effect against a variety of cancers, according to preliminary trial results released on...Tags: Drugs and Medicines, Trials, Medical Research, Litigation, New Haven (New Haven, Connecticut)
-
U.S. spending on medicines fell for first time in 2012
Reuters(Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....Tags: Plavix (drug), Patient Protection and Affordable Care Act, Lipitor (drug), AstraZeneca Plc, Flu
-
Spending on drugs falls for first time in 55 years
ReutersThe amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...Tags: Drugs and Medicines, Plavix (drug), Patents, Copyrights and Trademarks, Health Insurance Cost, Patient Protection and Affordable Care Act
-
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Drugs and Medicines, Medical Research, Diabetes, Schering Plough Corporation, Lipitor (drug)
-
REUTERS SUMMIT-Teva better suited than most for China market -CEO
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Bill Berkrot NEW YORK, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd has yet to make any serious inroads into China, but its chief executive...Tags: Drugs and Medicines, Restructuring and Recapitalization, IMS Health Incorporated, Joint Ventures, Israel
-
Lilly broadens diabetes offer with eye on bigger slice of booming market
Reuters* Head of diabetes says eyeing broadest portfolio in industry * Aiming to win bigger slice of growing market * Lilly currently No.4 in $40 bln diabetes market * Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt...Tags: Drugs and Medicines, Pharmaceuticals, Lilly Eli & Co, Diabetes, France
-
Eli Lilly amplía oferta en diabetes para reforzar presencia en mercado
ReutersPor Ludwig Burger y Frank Siebelt FRANCFORT (Reuters) - Eli Lilly, el cuarto fabricante mundial de medicamentos para la diabetes, buscará tener la variedad más amplia posible de fármacos antidiabéticos con el fin de ganar una mayor porción de ese...Tags: Lilly Eli & Co, Diabetes, Byetta (drug), Merck & Company Incorporated, AstraZeneca Plc
-
International consortium releases hepatitis C data
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...Tags: Financial Aid, Trials, University of North Carolina at Chapel Hill, Colleges and Universities, Education
May 19, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 2, 2013
|Story| South Florida Sun-Sentinel
Original site for Bristol Myers Squibb Company topic gallery.
